{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["naringenin", "natural medicine", "pharmacology", "phytochemistry", "polyphenols"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "33339267", "DateRevised": {"Year": "2020", "Month": "12", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "12", "Day": "16"}], "Language": ["eng"], "ELocationID": ["1784", "10.3390/plants9121784"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "9", "Issue": "12", "PubDate": {"Year": "2020", "Month": "Dec", "Day": "16"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "Multi-Therapeutic Potential of Naringenin (4',5,7-Trihydroxyflavonone): Experimental Evidence and Mechanisms.", "Abstract": {"AbstractText": ["Extensive research has been carried out during the last few decades, providing a detailed account of thousands of discovered phytochemicals and their biological activities that have the potential to be exploited for a wide variety of medicinal purposes. These phytochemicals, which are pharmacologically important for clinical use, primarily consist of polyphenols, followed by terpenoids and alkaloids. There are numerous published reports indicating the primary role of phytochemicals proven to possess therapeutic potential against several diseases. However, not all phytochemicals possess significant medicinal properties, and only some of them exhibit viable biological effects. Naringenin, a flavanone found in citrus fruits, is known to improve immunity, repair DNA damage, and scavenge free radicals. Despite the very low bioavailability of naringenin, it is known to exhibit various promising biological properties of medicinal importance, including anti-inflammatory and antioxidant activities. This review focuses on the various aspects related to naringenin, particularly its physicochemical, pharmacokinetic, and pharmacodynamic properties. Furthermore, various pharmacological activities of naringenin, such as anticancer, antidiabetic, hepatoprotective, neuroprotective, cardioprotective, nephroprotective, and gastroprotective effects, have been discussed along with their mechanisms of action."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box-2457, Riyadh-11451, Saudi Arabia."}], "LastName": "Arafah", "ForeName": "Azher", "Initials": "A"}, {"Identifier": ["0000-0002-9995-6576"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box-2457, Riyadh-11451, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Division of Veterinary Biochemistry, Faculty of Veterinary Science and Animal Husbandry, SKUAST-Kashmir, Alustang, Shuhama 190006, India."}], "LastName": "Rehman", "ForeName": "Muneeb U", "Initials": "MU"}, {"Identifier": ["0000-0002-7294-3660"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA."}], "LastName": "Mir", "ForeName": "Tahir Maqbool", "Initials": "TM"}, {"Identifier": ["0000-0003-1555-2820"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, RAK College of Pharmaceutical Sciences, RAK Medical and Health Science University, Ras Al Khaimah 11171, UAE."}], "LastName": "Wali", "ForeName": "Adil Farooq", "Initials": "AF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Veterinary Biochemistry, Faculty of Veterinary Science and Animal Husbandry, SKUAST-Kashmir, Alustang, Shuhama 190006, India."}], "LastName": "Ali", "ForeName": "Rayeesa", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology & Toxicology, and Central Lab, College of Pharmacy, King Saud University, P.O. Box-2457, Riyadh 11451, Saudi Arabia."}], "LastName": "Qamar", "ForeName": "Wajhul", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nano-therapeutics, Institute of Nano-science and Technology (DST-INST), Mohali, Punjab 160047, India."}], "LastName": "Khan", "ForeName": "Rehan", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box-2457, Riyadh-11451, Saudi Arabia."}], "LastName": "Ahmad", "ForeName": "Ajaz", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Medical Sciences, College of Medicine, King Saud bin Abdulaziz University (KSAU-HS), King Abdullah International Medical Research Centre (KAIMRC), Ministry of National Guard Health Affairs (NGHA), Jeddah 21423, Saudi Arabia."}], "LastName": "Aga", "ForeName": "Syed Sameer", "Initials": "SS"}, {"Identifier": ["0000-0002-3839-8187"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box-2457, Riyadh-11451, Saudi Arabia."}], "LastName": "Alqahtani", "ForeName": "Saeed", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, College of Pharmacy Girls Campus, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia."}], "LastName": "Almatroudi", "ForeName": "Nada M", "Initials": "NM"}], "GrantList": [{"GrantID": "RG-1441-397", "Agency": "King Saud University", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The authors declared no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Panche A.N., Diwan A.D., Chandra S.R. Flavonoids: An overview. J. Nutr. Sci. 2016;5:e47. doi: 10.1017/jns.2016.41.", "ArticleIdList": ["10.1017/jns.2016.41", "PMC5465813", "28620474"]}, {"Citation": "Tungmunnithum D., Thongboonyou A., Pholboon A., Yangsabai A. Flavonoids and Other Phenolic Compounds from Medicinal Plants for Pharmaceutical and Medical Aspects: An Overview. Medicines. 2018;5:93. doi: 10.3390/medicines5030093.", "ArticleIdList": ["10.3390/medicines5030093", "PMC6165118", "30149600"]}, {"Citation": "Samuelsen A.B. The traditional uses, chemical constituents and biological activities of Plantago major L. A review. J. Ethnopharmacol. 2000;71:1\u201321. doi: 10.1016/S0378-8741(00)00212-9.", "ArticleIdList": ["10.1016/S0378-8741(00)00212-9", "PMC7142308", "10904143"]}, {"Citation": "Patel K., Singh G.K., Patel D.K. A Review on Pharmacological and Analytical Aspects of Naringenin. Chin. J. Integr. Med. 2014;24:551\u2013560. doi: 10.1007/s11655-014-1960-x.", "ArticleIdList": ["10.1007/s11655-014-1960-x", "25501296"]}, {"Citation": "Rani N., Bharti S., Krishnamurthy B., Bhatia J., Sharma C., Kamal M.A., Ojha S., Arya D.S. Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical Promise. Curr. Pharm. Des. 2016;22:4341\u20134359. doi: 10.2174/1381612822666160530150936.", "ArticleIdList": ["10.2174/1381612822666160530150936", "27238365"]}, {"Citation": "Shakeel S., Rehman M.U., Tabassum N., Amin U. Effect of naringenin (A naturally occurring flavanone) against pilocarpine-induced status epilepticus and oxidative stress in mice. Pharm. Mag. 2017;13:154. doi: 10.4103/0973-1296.203977.", "ArticleIdList": ["10.4103/0973-1296.203977", "PMC5407108", "28479741"]}, {"Citation": "Mir I.A., Tiku A.B. Chemopreventive and therapeutic potential of \u201cnaringenin,\u201d a flavanone presents in citrus fruits. Nutr. Cancer. 2015;67:27\u201342. doi: 10.1080/01635581.2015.976320.", "ArticleIdList": ["10.1080/01635581.2015.976320", "25514618"]}, {"Citation": "Alam M.A., Subhan N., Rahman M.M., Uddin S.J., Reza S. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Adv. Nutr. 2014;5:404\u2013417. doi: 10.3945/an.113.005603.", "ArticleIdList": ["10.3945/an.113.005603", "PMC4085189", "25022990"]}, {"Citation": "Zaidun N.H., Thent Z.C., Latiff A.A. Combating oxidative stress disorders with citrus flavonoid: Naringenin. Life Sci. 2018;208:111\u2013122. doi: 10.1016/j.lfs.2018.07.017.", "ArticleIdList": ["10.1016/j.lfs.2018.07.017", "30021118"]}, {"Citation": "Zhou S., Hao T., Zhou J. Fermentation and metabolic pathway optimization to de novo synthesize (2S)-naringenin in Escherichia coli. J. Microbiol. Biotechnol. 2020 doi: 10.4014/jmb.2008.08005.", "ArticleIdList": ["10.4014/jmb.2008.08005", "32830192"]}, {"Citation": "Salehi B., Fokou P., Sharifi-Rad M., Zucca P., Pezzani R., Martins N., Sharifi-Rad J. The Therapeutic Potential of Naringenin: A Review of Clinical Trials. Pharmaceuticals. 2019;12:11. doi: 10.3390/ph12010011.", "ArticleIdList": ["10.3390/ph12010011", "PMC6469163", "30634637"]}, {"Citation": "Kumar S., Pandey A.K. Chemistry and biological activities of flavonoids: An overview. Sci. World J. 2013:62750. doi: 10.1155/2013/162750.", "ArticleIdList": ["10.1155/2013/162750", "PMC3891543", "24470791"]}, {"Citation": "Ji P., Yu T., Liu Y., Jiang J., Xu J., Zhao Y., Wu C. Naringenin-loaded solid lipid nanoparticles: Preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Drug Des. Dev. Ther. 2016;10:911. doi: 10.2147/DDDT.S97738.", "ArticleIdList": ["10.2147/DDDT.S97738", "PMC4780207", "27041995"]}, {"Citation": "Saleh T.M., Saleh M.C., Connell B.J., Song Y.H. A co-drug conjugate of naringenin and lipoic acid mediates neuroprotection in a rat model of oxidative stress. Clin. Exp. Pharmacol. Physiol. 2017;46:1008\u20131016. doi: 10.1111/1440-1681.12799.", "ArticleIdList": ["10.1111/1440-1681.12799", "28636787"]}, {"Citation": "Sun H., Dong T., Zhang A., Yang J., Yan G., Sakurai T., Wang X. Pharmacokinetics of hesperetin and naringenin in the Zhi Zhu Wan, a traditional Chinese medicinal formulae, and its pharmacodynamics study. Phytother. Res. 2013;27:1345\u20131351. doi: 10.1002/ptr.4867.", "ArticleIdList": ["10.1002/ptr.4867", "23148023"]}, {"Citation": "Kanaze F.I., Bounartzi M.I., Georgarakis M., Niopas I. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur. J. Clin. Nutr. 2007;61:472\u2013477. doi: 10.1038/sj.ejcn.1602543.", "ArticleIdList": ["10.1038/sj.ejcn.1602543", "17047689"]}, {"Citation": "Joshi R., Kulkarni Y.A., Wairkar S. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update. Life Sci. 2018;215:43\u201356. doi: 10.1016/j.lfs.2018.10.066.", "ArticleIdList": ["10.1016/j.lfs.2018.10.066", "30391464"]}, {"Citation": "Rivoira M.A., Rodriguez V., Talamoni G., Tolosa de Talamoni N. New Perspectives in the Pharmacological Potential of Naringin in Medicine. Curr. Med. Chem. 2020 doi: 10.2174/0929867327666200604171351.", "ArticleIdList": ["10.2174/0929867327666200604171351", "32496985"]}, {"Citation": "Ortiz-Andrade R., S\u00e1nchez-Salgado J., Navarrete-V\u00e1zquez G., Webster S., Binnie M., Garc\u00eda-Jim\u00e9nez S., Estrada-Soto S. Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes Obes. Metab. 2008;10:1097\u20131104. doi: 10.1111/j.1463-1326.2008.00869.x.", "ArticleIdList": ["10.1111/j.1463-1326.2008.00869.x", "18355329"]}, {"Citation": "Fuhr U., Klittich K., Staib A.H. Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br. J. Clin. Pharmacol. 1994;35:431\u2013436. doi: 10.1111/j.1365-2125.1993.tb04162.x.", "ArticleIdList": ["10.1111/j.1365-2125.1993.tb04162.x", "PMC1381556", "8485024"]}, {"Citation": "Fuhr U., Kummert A.L. The fate of naringin in humans: A key to grapefruit juice-drug interactions? Clin. Pharmacol. Ther. 1995;58:365\u2013373. doi: 10.1016/0009-9236(95)90048-9.", "ArticleIdList": ["10.1016/0009-9236(95)90048-9", "7586927"]}, {"Citation": "Katavic P.L., Lamb K., Navarro H., Prisinzano T.E. Flavonoids as Opioid Receptor Ligands: Identification and Preliminary Structure\u2212 Activity Relationships. J. Nat. Prod. 2007;70:1278\u20131282. doi: 10.1021/np070194x.", "ArticleIdList": ["10.1021/np070194x", "PMC2265593", "17685652"]}, {"Citation": "Renugadevi J., Prabu S.M. Cadmium-induced hepatotoxicity in rats and the protective effect of naringenin. Exp. Toxicol. Pathol. 2010;62:171\u2013181. doi: 10.1016/j.etp.2009.03.010.", "ArticleIdList": ["10.1016/j.etp.2009.03.010", "19409769"]}, {"Citation": "Francis A., Shetty T., Bhattacharya R. Modulating effect of plant flavonoids on the mutagenicity of N-methyl- N\u2032-nitro-N-nitrosoguanidine. Carcinogenesis. 1989;10:1953\u20131955. doi: 10.1093/carcin/10.10.1953.", "ArticleIdList": ["10.1093/carcin/10.10.1953", "2676226"]}, {"Citation": "Ekambaram G., Rajendran P., Magesh V., Sakthisekaran D. Naringenin reduces tumor size and weight lost in N-methyl-N\u2032-nitro-N-nitrosoguanidine\u2013induced gastric carcinogenesis in rats. Nutr. Res. 2008;28:106\u2013112. doi: 10.1016/j.nutres.2007.12.002.", "ArticleIdList": ["10.1016/j.nutres.2007.12.002", "19083396"]}, {"Citation": "Santos K.F.R., Oliveira T.T.D., Nagem T.J., Pinto A.D.S., Oliveira M.G. Hypolipidaemic effects of naringenin, rutin, nicotinic acid and their associations. Pharm. Res. 1999;40:493\u2013496. doi: 10.1006/phrs.1999.0556.", "ArticleIdList": ["10.1006/phrs.1999.0556", "10660947"]}, {"Citation": "Rayidi S., Pari L. Effect of naringenin on carbohydrate metabolism in streptozotocin-nicotinamide induced diabetic rats. Biomirror. 2011;2:12\u201319. doi: 10.1111/j.1463-1326.2008.00869.x.", "ArticleIdList": ["10.1111/j.1463-1326.2008.00869.x"]}, {"Citation": "Goldwasser J., Cohen P.Y., Yang E., Balaguer P., Yarmush M.L., Nahmias Y. Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: Role of PPAR\u03b1, PPAR\u03b3 and LXR\u03b1. PLoS ONE. 2010;5:12399. doi: 10.1371/journal.pone.0012399.", "ArticleIdList": ["10.1371/journal.pone.0012399", "PMC2928300", "20811644"]}, {"Citation": "Hollman P.C.H., Katan M.B. Dietary flavonoids: Intake, health effects and bioavailability. Food Chem. Toxicol. 1999;37:937\u2013942. doi: 10.1016/S0278-6915(99)00079-4.", "ArticleIdList": ["10.1016/S0278-6915(99)00079-4", "10541448"]}, {"Citation": "Sudhakar A. History of cancer, ancient and modern treatment methods. J. Cancer Sci. Ther. 2009;1:1\u20136. doi: 10.4172/1948-5956.100000e2.", "ArticleIdList": ["10.4172/1948-5956.100000e2", "20740081"]}, {"Citation": "Varghese F., Kabasakal B.V., Cotton C., Schumacher J., Rutherford A.W., Fantuzzi A., Murray J.W. A low-potential terminal oxidase associated with the iron-only nitrogenase from the nitrogen-fixing bacterium Azotobacter vinelandii. J. Biol. Chem. 2019;294:9367\u20139376. doi: 10.1074/jbc.RA118.007285.", "ArticleIdList": ["10.1074/jbc.RA118.007285", "PMC6579470", "31043481"]}, {"Citation": "Friesen C., Herr I., Krammer P.H., Debatin K.M. Involvement of the CD95 (APO\u20131/Fas) receptor/ligand system in drug\u2013induced apoptosis in leukemia cells. Nat. Med. 1996;2:574. doi: 10.1038/nm0596-574.", "ArticleIdList": ["10.1038/nm0596-574", "8616718"]}, {"Citation": "Durgo K., Koncar M., Komes D., Belscak-Cvitanovic A., Franekic J., Jakopovich I., Jakopovich B. Cytotoxicity of blended versus single medicinal mushroom extracts on human cancer cell lines: Contribution of polyphenol and polysaccharide content. Int. J. Med. Mushrooms. 2013;15:435\u2013448. doi: 10.1615/IntJMedMushr.v15.i5.20.", "ArticleIdList": ["10.1615/IntJMedMushr.v15.i5.20", "24266369"]}, {"Citation": "Ravishankar D., Rajora A.K., Greco F., Osborn H.M. Flavonoids as prospective compounds for anti-cancer therapy. Int. J. Biochem. Cell Biol. 2013;45:2821\u20132831. doi: 10.1016/j.biocel.2013.10.004.", "ArticleIdList": ["10.1016/j.biocel.2013.10.004", "24128857"]}, {"Citation": "Stefani E.D., Ronco A., Mendilaharsu M., Deneo-Pellegrini H. Diet and risk of cancer of the upper aerodigestive tract\u2014II. Nutrients. Oral Oncol. 1999;35:22\u201326. doi: 10.1016/S1368-8375(98)00061-X.", "ArticleIdList": ["10.1016/S1368-8375(98)00061-X", "10211306"]}, {"Citation": "Tiwari P., Mishra N.D. Role of flavonoids in DNA damage and carcinogenesis prevention. J. Carcinog. Mutagen. 2017;8:1\u20136. doi: 10.4172/2157-2518.1000297.", "ArticleIdList": ["10.4172/2157-2518.1000297"]}, {"Citation": "Moon Y.J., Wang X., Morris M.E. Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism. Toxicol. In Vitro. 2006;20:187\u2013210. doi: 10.1016/j.tiv.2005.06.048.", "ArticleIdList": ["10.1016/j.tiv.2005.06.048", "16289744"]}, {"Citation": "Brueggemeier R.W. Aromatase, aromatase inhibitors, and breast cancer. Am. J. Ther. 2001;8:333\u2013344. doi: 10.1097/00045391-200109000-00007.", "ArticleIdList": ["10.1097/00045391-200109000-00007", "11550075"]}, {"Citation": "Pouget C., Fagnere C., Basly J.P., Besson A.E., Champavier Y., Habrioux G., Chulia A.J. Synthesis and aromatase inhibitory activity of flavanones. Pharm. Res. 2002;19:286\u2013291. doi: 10.1023/A:1014490817731.", "ArticleIdList": ["10.1023/A:1014490817731", "11934235"]}, {"Citation": "Wilcox L.J., Borradaile N.M., Huff M.W. Antiatherogenic properties of naringenin, a citrus flavonoid. Cardiovasc. Ther. 1999;17:160\u2013178. doi: 10.1111/j.1527-3466.1999.tb00011.x.", "ArticleIdList": ["10.1111/j.1527-3466.1999.tb00011.x"]}, {"Citation": "Mutoh M., Takahashi M., Fukuda K., Komatsu H., Enya T., Matsushima-Hibiya Y., Wakabayashi K. Suppression by Flavonoids of Cyclooxygenase-2 Promoter-dependent Transcriptional Activity in Colon Cancer Cells: Structure-Activity Relationship. Cancer Sci. 2000;91:686\u2013691. doi: 10.1111/j.1349-7006.2000.tb01000.x.", "ArticleIdList": ["10.1111/j.1349-7006.2000.tb01000.x", "PMC5926411", "10920275"]}, {"Citation": "Rehman M.U., Rahman M.U., Farooq A., Rashid S.M., Ahmad B., Muzamil S. Naringenin (4,5,7-trihydroxyflavanone) suppresses the development of precancerous lesions via controlling hyperproliferation and inflammation in the colon of Wistar rats. Environ. Toxicol. 2018;33:422\u2013435. doi: 10.1002/tox.22528.", "ArticleIdList": ["10.1002/tox.22528", "29345053"]}, {"Citation": "Kawaii S., Tomono Y., Katase E., Ogawa K., Yano M. Antiproliferative activity of flavonoids on several cancer cell lines. Biosci. Biotechnol. Biochem. 1999;63:896\u2013899. doi: 10.1271/bbb.63.896.", "ArticleIdList": ["10.1271/bbb.63.896", "10380632"]}, {"Citation": "Pouget C., Lauthier F., Simon A., Fagnere C., Basly J.P., Delage C., Chulia A.J. Flavonoids: Structural requirements for antiproliferative activity on breast cancer cells. Bioorg. Med. Chem. Lett. 2001;11:3095\u20133097. doi: 10.1016/S0960-894X(01)00617-5.", "ArticleIdList": ["10.1016/S0960-894X(01)00617-5", "11720850"]}, {"Citation": "Chang W.S., Lee Y.J., Lu F.J., Chiang H.C. Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res. 1993;13:2165\u20132170.", "ArticleIdList": ["8297130"]}, {"Citation": "Iwashita K., Kobori M., Yamaki K., Tsushida T. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci. Biotechnol. Biochem. 2000;64:1813\u20131820. doi: 10.1271/bbb.64.1813.", "ArticleIdList": ["10.1271/bbb.64.1813", "11055382"]}, {"Citation": "Tanaka T., Kawabata K., Kakumoto M., Makita H., Hara A., Mori H., Kuki W. Citrus auraptene inhibits chemically induced colonic aberrant crypt foci in male F344 rats. Carcinogenesis. 1997;18:2155\u20132161. doi: 10.1093/carcin/18.11.2155.", "ArticleIdList": ["10.1093/carcin/18.11.2155", "9395216"]}, {"Citation": "Chandrika B.B., Steephan M., Kumar T.R.S., Sabu A., Haridas M. Hesperetin and Naringenin sensitize HER2 positive cancer cells to death by serving as HER2 Tyrosine Kinase inhibitors. Life Sci. 2016;1:47\u201356. doi: 10.1016/j.lfs.2016.07.007.", "ArticleIdList": ["10.1016/j.lfs.2016.07.007", "27449398"]}, {"Citation": "Choi J., Lee D.H., Jang H., Park S.Y., Seol J.W. Naringenin exerts anticancer effects by inducing tumor cell death and inhibiting angiogenesis in malignant melanoma. Int. J. Med. Sci. 2020;17:3049\u20133057. doi: 10.7150/ijms.44804.", "ArticleIdList": ["10.7150/ijms.44804", "PMC7646117", "33173425"]}, {"Citation": "Lin J.K., Chen Y.C., Huang Y.T., Lin-Shiau S.Y. Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin. J. Cell. Biochem. 1997;28:39\u201348. doi: 10.1002/(SICI)1097-4644(1997)28/29+<39::AID-JCB5>3.0.CO;2-X.", "ArticleIdList": ["10.1002/(SICI)1097-4644(1997)28/29+<39::AID-JCB5>3.0.CO;2-X", "9589348"]}, {"Citation": "Weber G., Shen F., Prajda N., Yang H., Li W., Yeh A., Look K.Y. Regulation of the signal transduction program by drugs. Adv. Enzym. Regul. 1995;37:35\u201355. doi: 10.1016/S0065-2571(96)00025-8.", "ArticleIdList": ["10.1016/S0065-2571(96)00025-8", "9381980"]}, {"Citation": "Arul D., Subramanian P. Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells. Pathol. Oncol. Res. 2013;19:763\u2013770. doi: 10.1007/s12253-013-9641-1.", "ArticleIdList": ["10.1007/s12253-013-9641-1", "23661153"]}, {"Citation": "Stoimenov I., Helleday T. PCNA on the crossroad of cancer. Pt 3Biochem. Soc. Trans. 2009;37:605\u2013613. doi: 10.1042/BST0370605.", "ArticleIdList": ["10.1042/BST0370605", "19442257"]}, {"Citation": "Strzalka W., Ziemienowicz A. Proliferating cell nuclear antigen (PCNA): A key factor in DNA replication and cell cycle regulation. Ann. Bot. 2010;107:1127\u20131140. doi: 10.1093/aob/mcq243.", "ArticleIdList": ["10.1093/aob/mcq243", "PMC3091797", "21169293"]}, {"Citation": "Chen Y.C., Shen S.C., Lin H.U. Rutinoside at C7 attenuates the apoptosis-inducing activity of flavonoids. Biochem. Pharmacol. 2003;66:1139\u20131150. doi: 10.1016/S0006-2952(03)00455-6.", "ArticleIdList": ["10.1016/S0006-2952(03)00455-6", "14505793"]}, {"Citation": "Zhao Z., Jin G., Ge Y., Guo Z. Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways. Inflammopharmacology. 2019;27:1021\u20131036. doi: 10.1007/s10787-018-00556-3.", "ArticleIdList": ["10.1007/s10787-018-00556-3", "30941613"]}, {"Citation": "Wang I.K., Lin-Shiau S.Y., Lin J.K. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur. J. Cancer. 1999;35:1517\u20131525. doi: 10.1016/S0959-8049(99)00168-9.", "ArticleIdList": ["10.1016/S0959-8049(99)00168-9", "10673981"]}, {"Citation": "Galluzzo P., Ascenzi P., Bulzomi P., Marino M. The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor \u03b1-palmitoylation. Endocrinology. 2008;149:2567\u20132575. doi: 10.1210/en.2007-1173.", "ArticleIdList": ["10.1210/en.2007-1173", "18239068"]}, {"Citation": "Totta P., Acconcia F., Leone S., Cardillo I., Marino M. Mechanisms of Naringenin-induced Apoptotic Cascade in Cancer Cells: Involvement of Estrogen Receptor a and \u00df Signalling. IUBMB. 2004;56:491\u2013499. doi: 10.1080/15216540400010792.", "ArticleIdList": ["10.1080/15216540400010792", "15545229"]}, {"Citation": "Bulzomi P., Bolli Z.Z., Galluzzo P., Leone S., Acconcia F., Marino M. Naringenin and 17\u03b2-estradiol coadministration prevents hormone-induced human cancer cell growth. IUBMB. 2010;62:51\u201360. doi: 10.1002/iub.279.", "ArticleIdList": ["10.1002/iub.279", "19960539"]}, {"Citation": "Morikawa K., Nonaka M., Mochizuki H., Handa K., Hanada H., Hirota K. Naringenin and hesperetin induce growth arrest, apoptosis, and cytoplasmic fat deposit in human preadipocytes. J. Agric. Food Chem. 2008;56:11030\u201311037. doi: 10.1021/jf801965n.", "ArticleIdList": ["10.1021/jf801965n", "18980325"]}, {"Citation": "Veiko A.G., Sekowski S., Lapshina E.A., Wilczewska A.Z., Markiewicz K.H., Zamaraeva M., Zhao H.-C., Zavodnik I.B. Flavonoids modulate liposomal membrane structure, regulate mitochondrial membrane permeability and prevent erythrocyte oxidative damage. Biochim. Biophys. Acta. 2020;1862:183442. doi: 10.1016/j.bbamem.2020.183442.", "ArticleIdList": ["10.1016/j.bbamem.2020.183442", "32814117"]}, {"Citation": "Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature. 2000;407:249. doi: 10.1038/35025220.", "ArticleIdList": ["10.1038/35025220", "11001068"]}, {"Citation": "Ferrara N., Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 1999;5:1359. doi: 10.1038/70928.", "ArticleIdList": ["10.1038/70928", "10581076"]}, {"Citation": "Tosetti F., Ferrari N., De Flora S., Albini A. Angioprevention\u2019: Angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J. 2002;16:2\u201314. doi: 10.1096/fj.01-0300rev.", "ArticleIdList": ["10.1096/fj.01-0300rev", "11772931"]}, {"Citation": "Anand K., Sarkar A., Kumar A., Ambasta P.K., Kumar P. Combinatorial antitumor effect of naringenin and curcumin elicit angioinhibitory activities in vivo. Nutr. Cancer. 2012;64:714\u2013724. doi: 10.1080/01635581.2012.686648.", "ArticleIdList": ["10.1080/01635581.2012.686648", "22642894"]}, {"Citation": "Lou C., Zhang F., Yang M., Zhao J., Zeng W., Fang X., Liang W. Naringenin decreases invasiveness and metastasis by inhibiting TGF-\u03b2-induced epithelial to mesenchymal transition in pancreatic cancer cells. PLoS ONE. 2012;7:50956. doi: 10.1371/journal.pone.0050956.", "ArticleIdList": ["10.1371/journal.pone.0050956", "PMC3530567", "23300530"]}, {"Citation": "Prabhakar P., Kumar A., Doble M. Combination therapy: A new strategy to manage diabetes and its complications. Phytomedicine. 2014;21:123\u2013130. doi: 10.1016/j.phymed.2013.08.020.", "ArticleIdList": ["10.1016/j.phymed.2013.08.020", "24074610"]}, {"Citation": "Barrett J.S., Gearry R.B., Muir J.G., Irving P.M., Rose R., Rosella O., Gibson P.R. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment. Pharmacol. Ther. 2010;31:874\u2013882. doi: 10.1111/j.1365-2036.2010.04237.x.", "ArticleIdList": ["10.1111/j.1365-2036.2010.04237.x", "20102355"]}, {"Citation": "Priscilla D.H., Roy D., Suresh A., Kumar V., Thirumurugan K. Naringenin inhibits \u03b1-glucosidase activity: A promising strategy for the regulation of postprandial hyperglycemia in high fat diet fed streptozotocin induced diabetic rats. Chem. -Biol. Interact. 2014;210:77\u201385. doi: 10.1016/j.cbi.2013.12.014.", "ArticleIdList": ["10.1016/j.cbi.2013.12.014", "24412302"]}, {"Citation": "S\u00e1nchez-Salgado J., Ortiz-Andrade R., Aguirre-Crespo F., Vergara-Galicia J., Le\u00f3n-Rivera I., Montes S., Estrada-Soto S. Hypoglycemic, vasorelaxant and hepatoprotective effects of Cochlospermum vitifolium (Willd.) Sprengel: A potential agent for the treatment of metabolic syndrome. J. Ethnopharmacol. 2007;109:400\u2013405. doi: 10.1016/j.jep.2006.08.008.", "ArticleIdList": ["10.1016/j.jep.2006.08.008", "16978815"]}, {"Citation": "Kannappan S., Anuradha C.V. Naringenin enhances insulin-stimulated tyrosine phosphorylation and improves the cellular actions of insulin in a dietary model of metabolic syndrome. Eur. J. Nutr. 2010;49:101\u2013109. doi: 10.1007/s00394-009-0054-6.", "ArticleIdList": ["10.1007/s00394-009-0054-6", "19727895"]}, {"Citation": "Mulvihill E., Allister E.M., Sutherland B.G., Telford D.E., Sawyez C.G., Edwards J.Y., Huff M.H. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor\u2013null mice with diet-induced insulin resistance. Diabetes. 2009;58:2198\u20132210. doi: 10.2337/db09-0634.", "ArticleIdList": ["10.2337/db09-0634", "PMC2750228", "19592617"]}, {"Citation": "Purushotham A., Tian M., Belury M. The citrus fruit flavonoid naringenin suppresses hepatic glucose production from Fao hepatoma cells. Mol. Nutr. Food Res. 2009;53:300\u2013307. doi: 10.1002/mnfr.200700514.", "ArticleIdList": ["10.1002/mnfr.200700514", "19035551"]}, {"Citation": "Creely S.J., McTernan P.G., Kusminski C.M., Fisher F.M., Silva N., Khanolkar M., Kumar S. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. 2007;292:740\u2013747. doi: 10.1152/ajpendo.00302.2006.", "ArticleIdList": ["10.1152/ajpendo.00302.2006", "17090751"]}, {"Citation": "Heo H.C., Kim M.J., Lee J.M., Choi S.J., Cho H.Y., Hong B., Shin D.H. Naringenin from Citrus junos has an inhibitory effect on acetylcholinesterase and a mitigating effect on amnesia. Dement. Geriatr. Cogn. Disord. 2004;17:151\u2013157. doi: 10.1159/000076349.", "ArticleIdList": ["10.1159/000076349", "14739537"]}, {"Citation": "Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid\u2013induced insulin resistance. J. Clin. Investig. 2006;11:3015\u20133025. doi: 10.1172/JCI28898.", "ArticleIdList": ["10.1172/JCI28898", "PMC1616196", "17053832"]}, {"Citation": "Yoshida H., Watanabe W., Oomagari H., Tsuruta E., Shida M., Kurokawa M. Citrus flavonoid naringenin inhibits TLR2 expression in adipocytes. J. Nutr. Biochem. 2013;24:1276\u20131284. doi: 10.1016/j.jnutbio.2012.10.003.", "ArticleIdList": ["10.1016/j.jnutbio.2012.10.003", "23333096"]}, {"Citation": "Yoshida H., Watanabe H., Ishida A., Watanabe W., Narumi K., Atsumi T., Kurokawa M. Naringenin suppresses macrophage infiltration into adipose tissue in an early phase of high-fat diet-induced obesity. Biochem. Biophys. Res. Commun. 2014;454:95\u2013101. doi: 10.1016/j.bbrc.2014.10.038.", "ArticleIdList": ["10.1016/j.bbrc.2014.10.038", "25450363"]}, {"Citation": "Ghofrani S., Joghataei M.T., Mohseni S., Baluchnejadmojarad T., Bagheri M., Khamse S., Roghani M. Naringenin improves learning and memory in an Alzheimer\u2019s disease rat model: Insights into the underlying mechanisms. Eur. J. Pharmacol. 2015;764:195\u2013201. doi: 10.1016/j.ejphar.2015.07.001.", "ArticleIdList": ["10.1016/j.ejphar.2015.07.001", "26148826"]}, {"Citation": "Krauss R.M. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care. 2004;27:1496\u20131504. doi: 10.2337/diacare.27.6.1496.", "ArticleIdList": ["10.2337/diacare.27.6.1496", "15161808"]}, {"Citation": "Borradaile N.M., de Dreu L.E., Huff M.W. Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation. Diabetes. 2003;52:2554\u20132561. doi: 10.2337/diabetes.52.10.2554.", "ArticleIdList": ["10.2337/diabetes.52.10.2554", "14514640"]}, {"Citation": "Ziegler D., Fonseca V. From guideline to patient: A review of recent recommendations for pharmacotherapy of painful diabetic neuropathy. J. Diabetes Complicat. 2015;29:146\u2013156. doi: 10.1016/j.jdiacomp.2014.08.008.", "ArticleIdList": ["10.1016/j.jdiacomp.2014.08.008", "25239450"]}, {"Citation": "Tesfaye S. Advances in the management of diabetic peripheral neuropathy. Curr. Opin. Supportive Palliat. Care. 2009;3:136\u2013143. doi: 10.1097/SPC.0b013e32832b7df5.", "ArticleIdList": ["10.1097/SPC.0b013e32832b7df5", "19421063"]}, {"Citation": "Tesfaye S., Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes/Metab. Res. Rev. 2012;28:8\u201314. doi: 10.1002/dmrr.2239.", "ArticleIdList": ["10.1002/dmrr.2239", "22271716"]}, {"Citation": "Hasanein P., Fuseli F. Role of naringenin in protection against diabetic hyperalgesia and tactile allodynia in male Wistar rats. J. Physiol. Biochem. 2014;70:997\u20131006. doi: 10.1007/s13105-014-0369-5.", "ArticleIdList": ["10.1007/s13105-014-0369-5", "25407136"]}, {"Citation": "Jain V., Jaggi A.S., Singh N. Ameliorative potential of rosiglitazone in tibial and sural nerve transection-induced painful neuropathy in rats. Pharmacol. Res. 2009;59:385\u2013392. doi: 10.1016/j.phrs.2009.02.001.", "ArticleIdList": ["10.1016/j.phrs.2009.02.001", "19429470"]}, {"Citation": "Freshwater J.D., Svensson C.I., Malmberg A.B., Calcutt N.A. Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes. 2002;51:2249\u20132255. doi: 10.2337/diabetes.51.7.2249.", "ArticleIdList": ["10.2337/diabetes.51.7.2249", "12086957"]}, {"Citation": "Rehman K., Khan I.I., Akash M., Jabeen K., Haider K. Naringenin downregulates inflammation-mediated nitric oxide overproduction and potentiates endogenous antioxidant status during hyperglycemia. J. Food Biochem. 2020:e13422. doi: 10.1111/jfbc.13422. advance online publication.", "ArticleIdList": ["10.1111/jfbc.13422", "32770581"]}, {"Citation": "Chao C.L., Weng C.S., Chang N.C., Lin J.S., Kao S.T., Ho F.M. Naringenin more effectively inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in macrophages than in microglia. Nutr. Res. 2010;30:858\u2013864. doi: 10.1016/j.nutres.2010.10.011.", "ArticleIdList": ["10.1016/j.nutres.2010.10.011", "21147369"]}, {"Citation": "Gill R.Q., Sterling R.K. Acute liver failure. J. Clin. Gastroenterol. 2001;33:191\u2013198. doi: 10.1097/00004836-200109000-00005.", "ArticleIdList": ["10.1097/00004836-200109000-00005", "11500606"]}, {"Citation": "Kullak-Ublick G.A., Andrade R.J., Merz M. Drug-induced liver injury: Recent advances in diagnosis and risk assessment. Gut. 2017;66:1154\u20131164. doi: 10.1136/gutjnl-2016-313369.", "ArticleIdList": ["10.1136/gutjnl-2016-313369", "PMC5532458", "28341748"]}, {"Citation": "El Golli-Bennour E., Timoumi R., Annaibi E., Mokni M., Omezzine A., Bacha H., Abid-Essefi S. Protective effects of kefir against deltamethrin-induced hepatotoxicity in rats. Envrion. Sci. Pollut. Res. Int. 2019;26:18856\u201318865. doi: 10.1007/s11356-019-05253-4.", "ArticleIdList": ["10.1007/s11356-019-05253-4", "31062243"]}, {"Citation": "Lee T.Y., Chang H.H., Wu M.Y., Lin H.C. Yin-Chen-Hao-Tang ameliorates obstruction-induced hepatic apoptosis in rats. J. Pharm. Pharmacol. 2007;59:583\u2013590. doi: 10.1211/jpp.59.4.0014.", "ArticleIdList": ["10.1211/jpp.59.4.0014", "17430643"]}, {"Citation": "Li S., Tan H.Y., Wang N., Zhang Z.J., Lao L., Wong C.W., Feng Y. Role of Oxidative Stress and Antioxidants in Liver Diseases. Int. J. Mol. Sci. 2015;16:26087\u201326124. doi: 10.3390/ijms161125942.", "ArticleIdList": ["10.3390/ijms161125942", "PMC4661801", "26540040"]}, {"Citation": "Hermenean A., Ardelean A., Stan M., Herman H., Mihali C.V., Costache M., Dinischiotu A. Protective effects of naringenin on carbon tetrachloride-induced acute nephrotoxicity in mouse kidney. Chem. Biol. Interact. 2013;205:138\u2013147. doi: 10.1016/j.cbi.2013.06.016.", "ArticleIdList": ["10.1016/j.cbi.2013.06.016", "23845967"]}, {"Citation": "Mershiba S.D., Dassprakash M.V., Saraswathy S.D. Protective effect of naringenin on hepatic and renal dysfunction and oxidative stress in arsenic intoxicated rats. Mol. Biol. Rep. 2013;40:3681\u20133691. doi: 10.1007/s11033-012-2444-8.", "ArticleIdList": ["10.1007/s11033-012-2444-8", "23283742"]}, {"Citation": "Renugadevi J., Prabu S.M. Naringenin protects against cadmium-induced oxidative renal dysfunction in rats. Toxicology. 2009;256:128\u2013134. doi: 10.1016/j.tox.2008.11.012.", "ArticleIdList": ["10.1016/j.tox.2008.11.012", "19063931"]}, {"Citation": "Hern\u00e1ndez-Aquino E., Muriel P. Beneficial effects of naringenin in liver diseases: Molecular mechanisms. World J. Gastroenterol. 2018;24:1679\u20131707. doi: 10.3748/wjg.v24.i16.1679.", "ArticleIdList": ["10.3748/wjg.v24.i16.1679", "PMC5922990", "29713125"]}, {"Citation": "Rashmi R., Magesh S.B., Mohanram R.K., Suryanarayanan S., Venkata SubbaRao M. Antioxidant Potential of Naringenin Helps to Protect Liver Tissue from Streptozotocin-Induced Damage. Rep. Biochem. Mol. Biol. 2018;7:76\u201384.", "ArticleIdList": ["PMC6175592", "30324121"]}, {"Citation": "Tauchen J., Huml L., Rimpelova S., Jur\u00e1\u0161ek M. Flavonoids and Related Members of the Aromatic Polyketide Group in Human Health and Disease: Do They Really Work? Molecules. 2020;25:3846. doi: 10.3390/molecules25173846.", "ArticleIdList": ["10.3390/molecules25173846", "PMC7504053", "32847100"]}, {"Citation": "Chetia P.P., Bala A., Khandelwal B., Haldar P. Comparative in vitro free radical scavenging property of \u00e2-carotene and naringenin with respect to vitamin C and N-acetyl cysteine. Pharmacologia. 2012;3:724\u2013728. doi: 10.5567/pharmacologia.2012.724.728.", "ArticleIdList": ["10.5567/pharmacologia.2012.724.728"]}, {"Citation": "Hern\u00e1ndez-Aquino E., Zarco N., Casas-Grajales S., Ramos-Tovar E., Flores-Beltr\u00e1n R.E., Arauz J., Shibayama M., Favari L., Tsutsumi V., Segovia J., et al. Naringenin prevents experimental liver fibrosis by blocking TGF\u03b2-Smad3 and JNK-Smad3 pathways. World J. Gastroenterol. 2017;23:4354\u20134368. doi: 10.3748/wjg.v23.i24.4354.", "ArticleIdList": ["10.3748/wjg.v23.i24.4354", "PMC5487499", "28706418"]}, {"Citation": "Moskaug J.O., Carlsen H., Myhrstad M.C., Blomhoff R. Polyphenols and glutathione synthesis regulation. Am. J. Clin. Nutr. 2005;81:277\u2013283. doi: 10.1093/ajcn/81.1.277S.", "ArticleIdList": ["10.1093/ajcn/81.1.277S", "15640491"]}, {"Citation": "Murata H., Takamatsu H., Liu S., Kataoka K., Huh N.H., Sakaguchi M. NRF2 Regulates PINK1 Expression under Oxidative Stress Conditions. PLoS ONE. 2015;10:e0142438. doi: 10.1371/journal.pone.0142438.", "ArticleIdList": ["10.1371/journal.pone.0142438", "PMC4640816", "26555609"]}, {"Citation": "Zeng W., Jin L., Zhang F., Zhang C., Liang W. Naringenin as a potential immunomodulator in therapeutics. Pharm. Res. 2018;135:122\u2013126. doi: 10.1016/j.phrs.2018.08.002.", "ArticleIdList": ["10.1016/j.phrs.2018.08.002", "30081177"]}, {"Citation": "Hermenean A., Ardelean A., Stan M., Hadaruga N., Mihali C.V., Costache M., Dinischiotu A. Antioxidant and hepatoprotective effects of naringenin and its \u03b2-cyclodextrin formulation in mice intoxicated with carbon tetrachloride: A comparative study. J. Med. Food. 2014;17:670\u2013677. doi: 10.1089/jmf.2013.0007.", "ArticleIdList": ["10.1089/jmf.2013.0007", "24611872"]}, {"Citation": "Yen F.L., Wu T.H., Lin L.T., Cham T.M., Lin C.C. Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl4-induced acute liver failure. Pharm. Res. 2007;26:893\u2013902. doi: 10.1007/s11095-008-9791-0.", "ArticleIdList": ["10.1007/s11095-008-9791-0", "19034626"]}, {"Citation": "Wu J., Huang G., Li Y., Li X. Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: Promising phytomedicines for the treatment of liver diseases. Chin. Med. 2020;15:89. doi: 10.1186/s13020-020-00371-5.", "ArticleIdList": ["10.1186/s13020-020-00371-5", "PMC7449045", "32863858"]}, {"Citation": "Wu J., Kuncio G.S., Zern M.A. Liver Growth Repair: From Basic Science to Clinical Practice. Chapman and Hall; London, UK: 1998."}, {"Citation": "Rajappa R., Sireesh D., Salai M.B., Ramkumar K.M., Sarvajayakesavulu S., Madhunapantula S.V. Treatment with naringenin elevates the activity of transcription factor nrf2 to protect pancreatic \u03b2-cells from streptozotocin-induced diabetes in vitro and in vivo. Front. Pharm. 2019;9:1562. doi: 10.3389/fphar.2018.01562.", "ArticleIdList": ["10.3389/fphar.2018.01562", "PMC6360183", "30745874"]}, {"Citation": "Kegel V., Pfeiffer E., Burkhardt B., Liu J.L., Zeilinger K., N\u00fcssler A.K., Seehofer D., Damm G. Subtoxic Concentrations of Hepatotoxic Drugs Lead to Kupffer Cell Activation in a Human in Vitro Liver Model: An Approach to Study DILI. Mediat. Inflamm. 2015;2015:640631. doi: 10.1155/2015/640631.", "ArticleIdList": ["10.1155/2015/640631", "PMC4600928", "26491234"]}, {"Citation": "Wells R.G. Cellular sources of extracellular matrix in hepatic fibrosis. Clin. Liver Dis. 2008;2:759\u2013768. doi: 10.1016/j.cld.2008.07.008.", "ArticleIdList": ["10.1016/j.cld.2008.07.008", "PMC2617723", "18984465"]}, {"Citation": "Arriazu E., Ruiz de Galarreta M., Cubero F.J., Varela-Rey M., P\u00e9rez de Obanos M.P., Leung T.M., Lopategi A., Benedicto A., Abraham-Enachescu I., Nieto N. Extracellular matrix and liver disease. Antioxid. Redox Signal. 2014;21:1078\u20131097. doi: 10.1089/ars.2013.5697.", "ArticleIdList": ["10.1089/ars.2013.5697", "PMC4123471", "24219114"]}, {"Citation": "Mahmoud A.M., Hernandez Bautista R.J., Sandhu M.A., Hussein O.E. Beneficial effects of citrus flavonoids on cardiovascular and metabolic health. Oxidative Med. Cell. Longev. 2019 doi: 10.1155/2019/5484138.", "ArticleIdList": ["10.1155/2019/5484138", "PMC6431442", "30962863"]}, {"Citation": "Chtourou Y., Fetoui H., Jemai R., Slima A.B., Makni M., Gdoura R. Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor \u03baB pathway. Eur. J. Pharmacol. 2015;746:96\u2013105. doi: 10.1016/j.ejphar.2014.10.027.", "ArticleIdList": ["10.1016/j.ejphar.2014.10.027", "25446569"]}, {"Citation": "Annadurai T., Thomas P., Geraldine P. Ameliorative effect of naringenin on hyperglycemia-mediated inflammation in hepatic and pancreatic tissues of Wistar rats with streptozotocin-nicotinamide-induced experimental diabetes mellitus. Free Radic. Res. 2013;47:793\u2013803. doi: 10.3109/10715762.2013.823643.", "ArticleIdList": ["10.3109/10715762.2013.823643", "23841752"]}, {"Citation": "Chen X., Guo C., Kong J. Oxidative stress in neurodegenerative diseases. Neural Regen. Res. 2012;7:376. doi: 10.3969/j.issn.1673-5374.2012.05.009.", "ArticleIdList": ["10.3969/j.issn.1673-5374.2012.05.009", "PMC4350122", "25774178"]}, {"Citation": "Drey M., Hasmann S.E., Krenovsky J.P., Hobert M.A., Straub S., Elshehabi M., Suenkel U. Associations between Early Markers of Parkinson\u2019s Disease and Sarcopenia. Front. Aging Neurosci. 2017;9:53. doi: 10.3389/fnagi.2017.00053.", "ArticleIdList": ["10.3389/fnagi.2017.00053", "PMC5339247", "28326036"]}, {"Citation": "Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 1968;5:107\u2013110. doi: 10.1016/0014-2999(68)90164-7.", "ArticleIdList": ["10.1016/0014-2999(68)90164-7", "5718510"]}, {"Citation": "Zbarsky V., Datla K.P., Parkar S., Rai D.K., Aruoma O.I., Dexter D.T. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson\u2019s disease. Free Radic. Res. 2005;39:1119\u20131125. doi: 10.1080/10715760500233113.", "ArticleIdList": ["10.1080/10715760500233113", "16298737"]}, {"Citation": "Tsai T.H. Determination of naringin in rat blood, brain, liver, and bile using microdialysis and its interaction with cyclosporin a, a p-glycoprotein modulator. J. Agric. Food Chem. 2002;50:6669\u20136674. doi: 10.1021/jf020603p.", "ArticleIdList": ["10.1021/jf020603p", "12405759"]}, {"Citation": "Youdim K.A., Dobbie M.S., Kuhnle G., Proteggente A.R., Abbott N.J., Rice-Evans C. Interaction between flavonoids and the blood\u2013brain barrier: In vitro studies. J. Neurochem. 2003;85:180\u2013192. doi: 10.1046/j.1471-4159.2003.01652.x.", "ArticleIdList": ["10.1046/j.1471-4159.2003.01652.x", "12641740"]}, {"Citation": "Nouri Z., Fakhri S., El-Senduny F.F., Sanadgol N., Abd-ElGhani G.E., Farzaei M.H., Chen J.T. On the Neuroprotective Effects of Naringenin: Pharmacological Targets, Signaling Pathways, Molecular Mechanisms, and Clinical Perspective. Biomolecules. 2019;9:690. doi: 10.3390/biom9110690.", "ArticleIdList": ["10.3390/biom9110690", "PMC6920995", "31684142"]}, {"Citation": "Angeline M.S., Sarkar A., Anand K., Ambasta R., Kumar P. Sesamol and naringenin reverse the effect of rotenone-induced PD rat model. Neuroscience. 2013;254:379\u2013394. doi: 10.1016/j.neuroscience.2013.09.029.", "ArticleIdList": ["10.1016/j.neuroscience.2013.09.029", "24070629"]}, {"Citation": "Yang W., Ma J., Liu Z., Lu Y., Hu B., Yu H. Effect of naringenin on brain insulin signaling and cognitive functions in ICV-STZ induced dementia model of rats. Neurol. Sci. 2014;35:741\u2013751. doi: 10.1007/s10072-013-1594-3.", "ArticleIdList": ["10.1007/s10072-013-1594-3", "24337945"]}, {"Citation": "Sarubbo F., Ramis M., Kienzer C., Aparicio S., Esteban S., Miralles A., Moranta D. Chronic silymarin, quercetin and naringenin treatments increase monoamines synthesis and hippocampal SIRT1 levels improving cognition in aged rats. J. Neuroimmune Pharmacol. 2018;13:24\u201338. doi: 10.1007/s11481-017-9759-0.", "ArticleIdList": ["10.1007/s11481-017-9759-0", "28808887"]}, {"Citation": "Raza S., Khan M., Ahmad A., Ashafaq M., Islam F., Wagner A., Safhi M. Neuroprotective effect of naringenin is mediated through suppression of NF-\u03baB signaling pathway in experimental stroke. Neuroscience. 2013;230:157\u2013171. doi: 10.1016/j.neuroscience.2012.10.041.", "ArticleIdList": ["10.1016/j.neuroscience.2012.10.041", "23103795"]}, {"Citation": "Bai X., Zhang X., Chen L., Zhang J., Zhang L., Zhao X., Zhao Y. Protective effect of naringenin in experimental ischemic stroke: Down-regulated NOD2, RIP2, NF-\u03baB, MMP-9 and up-regulated claudin-5 expression. Neurochem. Res. 2014;39:1405\u20131415. doi: 10.1007/s11064-014-1326-y.", "ArticleIdList": ["10.1007/s11064-014-1326-y", "24842554"]}, {"Citation": "Chtourou Y., Fetoui H., Gdoura R. Protective effects of naringenin on iron-overload-induced cerebral cortex neurotoxicity correlated with oxidative stress. Biol. Trace Elem. Res. 2014;158:376\u2013383. doi: 10.1007/s12011-014-9948-0.", "ArticleIdList": ["10.1007/s12011-014-9948-0", "24682942"]}, {"Citation": "Khan M.B., Khan M.M., Khan A., Ahmed M.E., Ishrat T., Tabassum R., Islam F. Naringenin ameliorates Alzheimer\u2019s disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in rat model. Neurochem. Int. 2012;61:1081\u20131093. doi: 10.1016/j.neuint.2012.07.025.", "ArticleIdList": ["10.1016/j.neuint.2012.07.025", "22898296"]}, {"Citation": "Liaquat L., Batool Z., Sadir S., Rafiq S., Shahzad S., Perveen T., Haider S. Naringenin-induced enhanced antioxidant defence system meliorates cholinergic neurotransmission and consolidates memory in male rats. Life Sci. 2017;194:213\u2013223. doi: 10.1016/j.lfs.2017.12.034.", "ArticleIdList": ["10.1016/j.lfs.2017.12.034", "29287782"]}, {"Citation": "Husain I., Bala K., Wani A., Makhdoomi U., Malik F., Sharma A. Arginase purified from endophytic Pseudomonas aeruginosa IH2: Induce apoptosis through both cell cycle arrest and MMP loss in human leukemic HL-60 cells. Chem. Biol. Interact. 2017;274:35\u201349. doi: 10.1016/j.cbi.2017.07.001.", "ArticleIdList": ["10.1016/j.cbi.2017.07.001", "28690100"]}, {"Citation": "Bala K., Husain I., Sharma A. Arginine deaminase from Pseudomonas aeruginosa PS2: Purification, biochemical characterization and in vitro evaluation of anticancer activity. 3 Biotech. 2020;10:1\u201317. doi: 10.1007/s13205-020-02212-6.", "ArticleIdList": ["10.1007/s13205-020-02212-6", "PMC7196117", "32373418"]}, {"Citation": "Orhan I., Nabavi S., Daglia M.C., Tenore G., Mansouri K., Nabavi S. Naringenin and atherosclerosis: A review of literature. Curr. Pharm. Biotechnol. 2015;16:245\u2013251. doi: 10.2174/1389201015666141202110216.", "ArticleIdList": ["10.2174/1389201015666141202110216", "25483717"]}, {"Citation": "Arafa H.M., Abd-Ellah M.F., Hafez H.F. Abatement by naringenin of doxorubicin-induced cardiac toxicity in rats. J. Egypt Natl. Canc. Inst. 2015;17:291\u2013300.", "ArticleIdList": ["17102822"]}, {"Citation": "Han X., Pan J., Ren D., Cheng Y., Fan F., Lou H. Naringenin-7-O-glucoside protects against doxorubicin-induced toxicity in H9c2 cardiomyocytes by induction of endogenous antioxidant enzymes. Food Chem. Toxicol. 2008;46:3140\u20133146. doi: 10.1016/j.fct.2008.06.086.", "ArticleIdList": ["10.1016/j.fct.2008.06.086", "18652870"]}, {"Citation": "Xu V.C., Chen J., Zhang J., Hu X., Zhou X., Lu Z.H. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress. Biol. Pharm. Bull. 2013;36:1549\u20131555. doi: 10.1248/bpb.b13-00247.", "ArticleIdList": ["10.1248/bpb.b13-00247", "23912743"]}, {"Citation": "Meng L.M., Ma H.J., Guo H., Kong Q.Q., Zhang Y. The cardioprotective effect of naringenin against ischemia\u2013reperfusion injury through activation of ATP-sensitive potassium channel in rat. Can. J. Physiol. Pharmacol. 2016;94:973\u2013978. doi: 10.1139/cjpp-2016-0008.", "ArticleIdList": ["10.1139/cjpp-2016-0008", "27408985"]}, {"Citation": "Testai L., Martelli A., Marino A., Antongiovanni V., Ciregia F., Giusti L., Calderone V. The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury. Biochem. Pharmacol. 2013;85:1634\u20131643. doi: 10.1016/j.bcp.2013.03.018.", "ArticleIdList": ["10.1016/j.bcp.2013.03.018", "23567997"]}, {"Citation": "Piccirillo G., Magr\u00ec D., Matera S., Magnanti M., Pasquazzi E., Schifano E., Paroli M. Effects of pink grapefruit juice on QT variability in patients with dilated or hypertensive cardiomyopathy and in healthy subjects. Transl. Res. 2008;151:267\u2013272. doi: 10.1016/j.trsl.2008.03.002.", "ArticleIdList": ["10.1016/j.trsl.2008.03.002", "18433709"]}, {"Citation": "Zhang N., Yang Z., Yuan Y., Li F., Liu Y., Ma Z., Zhou H. Naringenin attenuates pressure overload-induced cardiac hypertrophy. Exp. Ther. Med. 2015;10:2206\u20132212. doi: 10.3892/etm.2015.2816.", "ArticleIdList": ["10.3892/etm.2015.2816", "PMC4665326", "26668617"]}, {"Citation": "Huang H., Wu K., You Q., Huang R., Li S. Naringin inhibits high glucose-induced cardiomyocyte apoptosis by attenuating mitochondrial dysfunction and modulating the activation of the p38 signaling pathway. Int. J. Mol. Med. 2013;32:396\u2013402. doi: 10.3892/ijmm.2013.1403.", "ArticleIdList": ["10.3892/ijmm.2013.1403", "23732220"]}, {"Citation": "Moj\u017ei\u0161ov\u00e1 G., \u0160ari\u0161sk\u00fd M., Mirossay L., Martinka P., Moj\u017eis J. Effect of Flavonoids on Daunorubicin-induced Toxicity in H9c2 Cardiomyoblasts. Phytother. Res. 2009;23:136\u2013139. doi: 10.1002/ptr.2566.", "ArticleIdList": ["10.1002/ptr.2566", "18803248"]}, {"Citation": "Mulvihill E.E., Assini S.B.G., DiMattia A.S., Khami M., Koppes J.B., Huff M.W. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in highfatfed lowdensity lipoprotein receptornull mice. Arterioscler. Thromb. Vasc. Biol. 2010;30:742\u2013748. doi: 10.1161/ATVBAHA.109.201095.", "ArticleIdList": ["10.1161/ATVBAHA.109.201095", "20110573"]}, {"Citation": "Soetikno V., Arozal W., Louisa M., Setiabudy R. New insight into the molecular drug target of diabetic nephropathy. Int. J. Endocrinol. 2014;2014:968681. doi: 10.1155/2014/968681.", "ArticleIdList": ["10.1155/2014/968681", "PMC3932220", "24648839"]}, {"Citation": "Arozal W., Watanabe K., Veeraveedu P.T., Thandavarayan R.A., Sukumaran V., Aizawa Y. Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-\u03b3 agonist actions. Toxicology. 2011;279:91\u201399. doi: 10.1016/j.tox.2010.09.013.", "ArticleIdList": ["10.1016/j.tox.2010.09.013", "20888384"]}, {"Citation": "Esteban V., Lorenzo O., Rup\u00e9rez M., Suzuki Y., Mezzano S., Blanco J., Ruiz-Ortega M. Angiotensin II, via AT1 and AT2 receptors and NF-\u03baB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J. Am. Soc. Nephrol. 2004;15:1514\u20131529. doi: 10.1097/01.ASN.0000130564.75008.F5.", "ArticleIdList": ["10.1097/01.ASN.0000130564.75008.F5", "15153562"]}, {"Citation": "Ozbek E., Ilbey Y.O., Ozbek M., Simsek A., Cekmen M., Somay A. Melatonin attenuates unilateral ureteral obstruction\u2013induced renal injury by reducing oxidative stress, iNOS, MAPK, and NF-kB expression. J. Endourol. 2009;23:1165\u20131173. doi: 10.1089/end.2009.0035.", "ArticleIdList": ["10.1089/end.2009.0035", "19530942"]}, {"Citation": "Karuppagounder V., Arumugam S., Thandavarayan R.A., Pitchaimani V., Sreedhar R., Afrin R., Nakamura M. Naringenin ameliorates daunorubicin induced nephrotoxicity by mitigating AT1R, ERK1/2-NF\u03baB p65 mediated inflammation. Int. Immunopharmacol. 2015;28:154\u2013159. doi: 10.1016/j.intimp.2015.05.050.", "ArticleIdList": ["10.1016/j.intimp.2015.05.050", "26072060"]}, {"Citation": "Fouad A.A., Albuali W.H., Zahran A., Gomaa W. Protective effect of naringenin against gentamicin-induced nephrotoxicity in rats. Environ. Toxicol. Pharmacol. 2014;38:420\u2013429. doi: 10.1016/j.etap.2014.07.015.", "ArticleIdList": ["10.1016/j.etap.2014.07.015", "25128772"]}, {"Citation": "Badary O.A., Abdel-Maksoud S., Ahmed W.A., Owieda G.H. Naringenin attenuates cisplatin nephrotoxicity in rats. Life Sci. 2005;76:2125\u20132135. doi: 10.1016/j.lfs.2004.11.005.", "ArticleIdList": ["10.1016/j.lfs.2004.11.005", "15826879"]}, {"Citation": "Schrezenmeier E.V., Barasch J., Budde K., Westhoff T., Schmidt-Ott K.M. Biomarkers in acute kidney injury\u2014Pathophysiological basis and clinical performance. Acta Physiol. 2017;219:554\u2013572. doi: 10.1111/apha.12764.", "ArticleIdList": ["10.1111/apha.12764", "PMC5575831", "27474473"]}, {"Citation": "Cheung C.H.A., Huang C.C., Tsai F.Y., Lee J.Y.C., Cheng S.M., Chang Y.C., Chang J.Y. Survivin\u2013biology and potential as a therapeutic target in oncology. OncoTargets Ther. 2013;6:1453. doi: 10.2147/OTT.S33374.", "ArticleIdList": ["10.2147/OTT.S33374", "PMC3804542", "24204160"]}, {"Citation": "Hossain M.M., Banik N.L., Ray S.K. Survivin knockdown increased anti-cancer effects of (\u2212)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells. Exp. Cell Res. 2012;318:1597\u20131610. doi: 10.1016/j.yexcr.2012.03.033.", "ArticleIdList": ["10.1016/j.yexcr.2012.03.033", "PMC3374045", "22507272"]}, {"Citation": "Orrego-Lagar\u00f3n N., Mart\u00ednez-Hu\u00e9lamo M., Vallverd\u00fa-Queralt A., Lamuela-Raventos R.M., Escribano-Ferrer E. High gastrointestinal permeability and local metabolism of naringenin: Influence of antibiotic treatment on absorption and metabolism. Br. J. Nutr. 2015;114:169\u2013180. doi: 10.1017/S0007114515001671.", "ArticleIdList": ["10.1017/S0007114515001671", "26083965"]}, {"Citation": "Yang J., Li Q., Zhou X., Kolosov V., Perelman J. Naringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-\u03baB activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human airway epithelial cells. Mol. Cell. Biochem. 2011;351:29\u201340. doi: 10.1007/s11010-010-0708-y.", "ArticleIdList": ["10.1007/s11010-010-0708-y", "21229383"]}, {"Citation": "Al-Rejaie S.S., Abuohashish H.M., Al-Enazi M.M., Al-Assaf A.H., Parmar M.Y., Ahmed M.M. Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats. World J. Gastroenterol. 2013;19:5633\u20135644. doi: 10.3748/wjg.v19.i34.5633.", "ArticleIdList": ["10.3748/wjg.v19.i34.5633", "PMC3769899", "24039355"]}, {"Citation": "Dou W., Zhang J., Sun A., Zhang E., Ding L., Mukherjee S., Mani S. Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-\u03baB signalling. Br. J. Nutr. 2013;110:599\u2013608. doi: 10.1017/S0007114512005594.", "ArticleIdList": ["10.1017/S0007114512005594", "PMC3726555", "23506745"]}, {"Citation": "Manabe N., Wong B.S., Camilleri M. New-generation 5-HT4 receptor agonists: Potential for treatment of gastrointestinal motility disorders. Expert Opin. Investig. Drugs. 2010;19:765\u2013775. doi: 10.1517/13543784.2010.482927.", "ArticleIdList": ["10.1517/13543784.2010.482927", "20408739"]}, {"Citation": "Peeters T.L. Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders. Curr. Opin. Pharmacol. 2006;6:553\u2013558. doi: 10.1016/j.coph.2006.08.005.", "ArticleIdList": ["10.1016/j.coph.2006.08.005", "17011824"]}, {"Citation": "Jang Y., Kim S.W., Oh J., Hong G.S., Seo E.K., Oh U., Shim W.S. Ghrelin receptor is activated by naringin and naringenin, constituents of a prokinetic agent Poncirus fructus. J. Ethnopharmacol. 2013;148:459\u2013465. doi: 10.1016/j.jep.2013.04.039.", "ArticleIdList": ["10.1016/j.jep.2013.04.039", "23639361"]}, {"Citation": "Bao L., Liu F., Guo H., Li Y., Tan B., Zhang W., Peng Y. Naringenin inhibits proliferation, migration, and invasion as well as induces apoptosis of gastric cancer SGC7901 cell line by downregulation of AKT pathway. Tumor Biol. 2016;37:11365\u201311374. doi: 10.1007/s13277-016-5013-2.", "ArticleIdList": ["10.1007/s13277-016-5013-2", "26960693"]}, {"Citation": "Zhang H., Zhong X., Zhang X., Shang D., Zhou Y., Zhang C. Enhanced anticancer effect of ABT-737 in combination with naringenin on gastric cancer cells. Exp. Ther. Med. 2016;11:669\u2013673. doi: 10.3892/etm.2015.2912.", "ArticleIdList": ["10.3892/etm.2015.2912", "PMC4734232", "26893664"]}, {"Citation": "Chin L.H., Hon C.M., Chellappan D.K., Chellian J., Madheswaran T., Zeeshan F., Awasthi R., Aljabali A.A., Tambuwala M.M., Dureja H., et al. Molecular mechanisms of action of naringenin in chronic airway diseases. Eur. J. Pharmacol. 2020;879:173139. doi: 10.1016/j.ejphar.2020.173139.", "ArticleIdList": ["10.1016/j.ejphar.2020.173139", "32343971"]}, {"Citation": "Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb. Perspect. Biol. 2009;1:a001651. doi: 10.1101/cshperspect.a001651.", "ArticleIdList": ["10.1101/cshperspect.a001651", "PMC2882124", "20457564"]}, {"Citation": "Kim T.M., Paudel K.R., Kim D.W. Eriobotrya japonica leaf extract attenuates airway inflammation in ovalbumin-induced mice model of asthma. J. Ethnopharmacol. 2020;253:112082. doi: 10.1016/j.jep.2019.112082.", "ArticleIdList": ["10.1016/j.jep.2019.112082", "31310829"]}, {"Citation": "Gorniak I., Bartoszewski R., Kroliczewski J. Comprehensive review of antimicrobial activities of plant flavonoids. Phytochem. Rev. 2019;18:241\u2013272. doi: 10.1007/s11101-018-9591-z.", "ArticleIdList": ["10.1007/s11101-018-9591-z"]}, {"Citation": "Koz\u0142owska J., Potaniec B., \u017barowska B., Anio\u0142 M. Synthesis and Biological Activity of Novel O-Alkyl Derivatives of Naringenin and Their Oximes. Molecules. 2017;22:1485. doi: 10.3390/molecules22091485.", "ArticleIdList": ["10.3390/molecules22091485", "PMC6151618", "28878189"]}, {"Citation": "Duda-Madej A., Koz\u0142owska J., Krzy\u017cek P., Anio\u0142 M., Seniuk A., Jermakow K., Dworniczek E. Antimicrobial O-Alkyl Derivatives of Naringenin and Their Oximes Against Multidrug-Resistant Bacteria. Molecules. 2020;25:3642. doi: 10.3390/molecules25163642.", "ArticleIdList": ["10.3390/molecules25163642", "PMC7464300", "32785151"]}, {"Citation": "Tran Trung H., Truong Thi Huynh H., Nguyen Thi Thuy L., Nguyen Van Minh H., Thi Nguyen M.N., Luong Thi M.N. Growth-Inhibiting, Bactericidal, Antibiofilm, and Urease Inhibitory Activities of Hibiscus rosa sinensis L. Flower Constituents toward Antibiotic Sensitive- and Resistant-Strains of Helicobacter pylori. ACS Omega. 2020;5:20080\u201320089. doi: 10.1021/acsomega.0c01640.", "ArticleIdList": ["10.1021/acsomega.0c01640", "PMC7439261", "32832762"]}, {"Citation": "Vikram A., Jayaprakasha G.K., Jesudhasan P.R., Pillai S.D., Patil B.S. Suppression of bacterial cell-cell signalling, biofilm formation and type III secretion system by citrus flavonoids. J. Appl. Microbiol. 2010;109:515\u2013527. doi: 10.1111/j.1365-2672.2010.04677.x.", "ArticleIdList": ["10.1111/j.1365-2672.2010.04677.x", "20163489"]}]}], "History": [{"Year": "2020", "Month": "8", "Day": "27"}, {"Year": "2020", "Month": "11", "Day": "26"}, {"Year": "2020", "Month": "11", "Day": "26"}, {"Year": "2020", "Month": "12", "Day": "19", "Hour": "1", "Minute": "2"}, {"Year": "2020", "Month": "12", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "20", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "12", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["33339267", "PMC7766900", "10.3390/plants9121784", "plants9121784"]}}]}